Dash Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
41
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$30M
- Investors
-
11
Dash Bio General Information
Description
Developer of a clinical bioanalysis platform intended to offer tech-enabled services for drug development. The company's platform adapts a technology-first approach to developing critical services across the drug development lifecycle, aiming to build new capabilities that leverage AI, robotics, and fully integrated software to deliver GLP-compliant services, enabling users to automate critical steps, reduce costs, and shorten time to market without compromising on quality.
Contact Information
Website
www.dash.bioCorporate Office
- 56 Broad Street
- Suite 14011
- Boston, MA 02109
- United States
Corporate Office
- 56 Broad Street
- Suite 14011
- Boston, MA 02109
- United States
Dash Bio Timeline
Dash Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 03-Aug-2026 | $30M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 26-Jun-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 08-Oct-2024 | $6.47M | $6.47M | Completed | Generating Revenue |
Dash Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 3,035,390 | $0.000010 | $3.21 | $3.21 | 1x | $3.21 | 12.95% | |
| Seed-1 | 3,632,576 | $0.000010 | $1.78 | $1.78 | 1x | $1.78 | 15.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Dash Bio Signals
Dash Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Oak HC/FT | Venture Capital | Minority | ||
| Cybernetix Ventures | Venture Capital | Minority | ||
| Drive Capital | Venture Capital | Minority | ||
| RTP Global | Venture Capital | Minority | ||
| The Aligned Fund | Venture Capital | Minority |
Dash Bio FAQs
-
When was Dash Bio founded?
Dash Bio was founded in 2024.
-
Where is Dash Bio headquartered?
Dash Bio is headquartered in Boston, MA.
-
What is the size of Dash Bio?
Dash Bio has 41 total employees.
-
What industry is Dash Bio in?
Dash Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Dash Bio a private or public company?
Dash Bio is a Private company.
-
What is the current valuation of Dash Bio?
The current valuation of Dash Bio is .
-
What is Dash Bio’s current revenue?
The current revenue for Dash Bio is .
-
How much funding has Dash Bio raised over time?
Dash Bio has raised $47.5M.
-
Who are Dash Bio’s investors?
Oak HC/FT, Cybernetix Ventures, Drive Capital, RTP Global, and The Aligned Fund are 5 of 11 investors who have invested in Dash Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process